318 related articles for article (PubMed ID: 24459778)
1. GMPs vs GCPs: manufacturing and compounding definitions.
Allen LV
Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778
[No Abstract] [Full Text] [Related]
2. GMPs vs GCPs: United States Pharmacopeia General Chapters.
Allen LV
Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791
[No Abstract] [Full Text] [Related]
3. Compounding pharmacies: before and after an inspection.
Kulkarni D; Ricketts S
Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
[TBL] [Abstract][Full Text] [Related]
4. Drug product quality.
Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
[No Abstract] [Full Text] [Related]
5. Report on the PQRI impurity characterization and quantification best practices survey.
Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
[No Abstract] [Full Text] [Related]
6. The U.S. Food and Drug Administration responds to the International Academy of Compounding Pharmacists' outsourcing letter.
Int J Pharm Compd; 2014; 18(3):208. PubMed ID: 25306767
[No Abstract] [Full Text] [Related]
7. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
Jimenez FA
Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
[No Abstract] [Full Text] [Related]
8. 2013 State Compounding Legislation Tracker.
Miller DG
Int J Pharm Compd; 2013; 17(5):375-8. PubMed ID: 24459782
[No Abstract] [Full Text] [Related]
9. US drug shortages are set to reach record high in 2011, report says.
Tanne JH
BMJ; 2011 Dec; 343():d8307. PubMed ID: 22194406
[No Abstract] [Full Text] [Related]
10. Drug safety: the viewpoint of the pharmaceutical manufacturing industry.
Wigle WW
Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099
[No Abstract] [Full Text] [Related]
11. GMPs and GCPs: a topical comparison.
Allen LV
Int J Pharm Compd; 2013; 17(1):87. PubMed ID: 23627250
[No Abstract] [Full Text] [Related]
12. New recommendations to modernize drug manufacturing.
FDA Consum; 2007; 41(1):4. PubMed ID: 17354283
[No Abstract] [Full Text] [Related]
13. Current good manufacturing practices for PET drug products in the United States.
Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ
J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213
[No Abstract] [Full Text] [Related]
14. FDA, states discuss pharmacy compounding regulatory framework.
Traynor K
Am J Health Syst Pharm; 2013 Feb; 70(3):180, 182. PubMed ID: 23327976
[No Abstract] [Full Text] [Related]
15. Meningitis outbreak shines light on compounding pharmacies.
Shaughnessy AF
BMJ; 2012 Nov; 345():e7432. PubMed ID: 23129491
[No Abstract] [Full Text] [Related]
16. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
Hyde TD
Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
[TBL] [Abstract][Full Text] [Related]
17. Regulation of compounding by the food and drug administration: a tale of 2 circuits.
Williams KG
J Pharm Pract; 2010 Oct; 23(5):502-6. PubMed ID: 21507854
[TBL] [Abstract][Full Text] [Related]
18. What is quality of medicines?
Doogue MP; Thynne TR
Intern Med J; 2013 Oct; 43(10):1057-8. PubMed ID: 24134167
[No Abstract] [Full Text] [Related]
19. Manufacturing and standardizing allergen extracts in Europe.
Larsen JN; Houghton CG; Løwenstein H; Lombardero M
Clin Allergy Immunol; 2004; 18():433-55. PubMed ID: 15042928
[No Abstract] [Full Text] [Related]
20. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
